Sean Lee
Stock Analyst at HC Wainwright & Co.
(1.92)
# 1267
Out of 5,370 analysts
110
Total ratings
38.60%
Success rate
29.89%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SENS Senseonics Holdings | Assumes: Buy | 2 | 0.51 | 115.69% | 1 | Jun 2, 2025 | |
CASI CASI Pharmaceuticals | Reiterates: Buy | 4 4 | 1.3 | 207.69% | 9 | May 19, 2025 | |
CTSO CytoSorbents | Reiterates: Neutral | 1 1 | 1.25 | -20% | 13 | May 15, 2025 | |
VSTM Verastem | Maintains: Strong Buy | 10 14 | 5.62 | 149.11% | 14 | May 9, 2025 | |
DWTX Dogwood Therapeutics | Upgrades: Buy | 10 | 4.81 | 107.9% | 1 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 20 20 | 10.98 | 82.15% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 40 40 | 34.36 | 16.41% | 10 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 6 | n/a | n/a | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 11 11 | 4.23 | 160.05% | 3 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 8 10 | 2.79 | 240.5% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 5 | n/a | n/a | 4 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 1 | n/a | n/a | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 100 100 | 9.2 | 986.96% | 4 | Jul 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | n/a | n/a | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | 1.09 | 2652.29% | 1 | Dec 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Mar 19, 2021 |